An illicit reduction.
Shotwell
J Brad
JB
GlaxoSmithKline, R&D, Research Triangle Park, NC 27709, USA. John.B.Shotwell@GSK.com
D004809:Ephedrine; D006801:Humans; D013287:Illicit Drugs / Q000138:chemical synthesis / Q000331:legislation & jurisprudence*; D008694:Methamphetamine / Q000138:chemical synthesis*; D037041:United States Government Agencies